34 results on '"Hartkopf, Andreas Daniel"'
Search Results
2. Immuntherapie in der gynäkologischen Onkologie und Senologie
Catalog
Books, media, physical & digital resources
3. Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.
4. Circulating Tumor DNA in Early and Metastatic Breast Cance—Current Role and What Is Coming Next.
5. Breast Cancer and Mental Health: Incidence and Influencing Factors—A Claims Data Analysis from Germany.
6. The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.
7. Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer
8. Vergleich von Trastuzumab-Biosimilar ABP 980 mit Referenz-Trastuzumab bei der neoadjuvanten Therapie von HER2-positivem Brustkrebs – Analyse eines großen universitären Brustkrebszentrums
9. Adverse Obstetric Outcomes after Breast Cancer Diagnosis: An Observational Database Study in Germany.
10. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020
11. Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.
12. The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers
13. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center
14. Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast Centers
15. Immunotherapy in breast cancer and gynecologic oncology
16. Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer—A Population-Based Study.
17. Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database
18. Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
19. Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre.
20. Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer
21. Verteilung des 21-Gen-Rezidiv-Scores bei Patientinnen mit primärem Mammakarzinom in Deutschland
22. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
23. Distribution of the 21-Gene Breast Recurrence Score in Patients with Primary Breast Cancer in Germany
24. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
25. ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification
26. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
27. ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification.
28. CAPTOR-BC: Comprehensive analysis of spatial, temporal and molecular biomarkers predicting response and resistance to first-line treatment with ribociclib + ET in HR+, HER2- advanced breast cancer.
29. Influence of adherence to adjuvant endocrine therapy in early breast cancer: Results from a large German real-world claims data analysis.
30. Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
31. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients
32. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
33. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
34. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.